Search
27/02/2023
Last twenty-years activity of cardiovascular tissue banking in Barcelona
Castells-Sala C., Pérez M.L., Agustí E., Aiti A., Tarragona E., Navarro A., Tabera J., Farinas, O, Pomar J.L., Vilarrodona A.. Last twenty-years activity of cardiovascular tissue banking in Barcelona. CELL AND TISSUE BANKING. 2023; DOI:10.1007/s10561-022-10059-9. PMID:36849631. IF:1.400(Q4/9D).
01/01/2023
Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies
Lopez-Chicon, P, Perez, ML, Castells-Sala, C, Piteria, RA, Farinas, O, Tabera, J, Vilarrodona, A. Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies. Therapeutics and Clinical Risk Management. 2023; 19DOI:10.2147/TCRM.S410574. PMID:37425344. IF:2.300(Q2/5D).
01/01/2023
Can Synbone® cylinders and deer femurs reproduce ballistic fracture patterns observed in human long bones?
Schwab N., Jordana X., Soler J., Garrido X., Brillas P., Savio A., Lavín S., Ortega-Sánchez M., Galtés I.. Can Synbone® cylinders and deer femurs reproduce ballistic fracture patterns observed in human long bones?. JOURNAL OF MATERIALS SCIENCE. 2023; 58(11)DOI:10.1007/s10853-023-08333-6. PMID:. IF:3.500(Q2/5D).
01/12/2022
A novel decellularized nerve graft for repairing peripheral nerve long gap injury in the rat
Contreras, E, Bolivar, S, Nieto-Nicolau, N, Farinas, O, Lopez-Chicon, P, Navarro, X, Udina, E. A novel decellularized nerve graft for repairing peripheral nerve long gap injury in the rat. CELL AND TISSUE RESEARCH. 2022; 390(3)DOI:10.1007/s00441-022-03682-1. PMID:36114915. IF:3.600(Q3/7D).
01/09/2022
Amniotic membrane extract eye drops: a new approach to severe ocular surface pathologies
Perez, ML, Barreales, S, Sabater-Cruz, N, Martinez-Conesa, EM, Vilarrodona, A, Casaroli-Marano, RP. Amniotic membrane extract eye drops: a new approach to severe ocular surface pathologies. CELL AND TISSUE BANKING. 2022; 23(3)DOI:10.1007/s10561-021-09962-4. PMID:34549352. IF:1.500(Q4/9D).
01/06/2022
Lyophilized amniotic membrane graft for primary pterygium surgery: preliminary results
Sabater-Cruz, N, Martinez-Conesa, E, Vilarrodona, A, Casaroli-Marano, RP. Lyophilized amniotic membrane graft for primary pterygium surgery: preliminary results. CELL AND TISSUE BANKING. 2022; 23(2)DOI:10.1007/s10561-021-09955-3. PMID:34628551. IF:1.500(Q4/9D).
01/02/2022
"Off-the-Shelf" Nerve Matrix Preservation
Nieto-Nicolau, N, Lopez-Chicon, P, Torrico, C, Bolivar, S, Contreras-Carreton, E, Udina, E, Navarro, X, Casaroli-Marano, RP, Farinas, O, Vilarrodona, A. "Off-the-Shelf" Nerve Matrix Preservation. Biopreservation and Biobanking. 2022; 20(1)DOI:10.1089/bio.2020.0158. PMID:34542324. IF:1.600(Q3/7D).
01/01/2022
Comparison of a human acellular dermal matrix and a polypropylene mesh for pelvic floor reconstruction: a randomized trial study in a rabbit model
Pero M., Castells-Sala C., Alserawan L., Casani L., Juan Babot J.O., Jorba I., Pérez M.L., Moga E., Otero J., López-Chicón P., Badimon L., Vilarrodona Serrat A., Porta-Roda O.. Comparison of a human acellular dermal matrix and a polypropylene mesh for pelvic floor reconstruction: a randomized trial study in a rabbit model. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-22190-4. PMID:36450745. IF:4.600(Q2/4D).
01/11/2021
Eye bank and theatre factors for positive microbiological culture of corneoscleral rim and cornea storage medium in the real-world
Sabater-Cruz, N, Otero, N, Dotti-Boada, M, Rios, J, Gris, O, Guell, JL, Vilarrodona, A, Casaroli-Marano, RP. Eye bank and theatre factors for positive microbiological culture of corneoscleral rim and cornea storage medium in the real-world. EYE. 2021; 35(11)DOI:10.1038/s41433-020-01342-8. PMID:33469128. IF:4.456(Q1/2D).
01/10/2021
Fast protocol for the processing of split-thickness skin into decellularized human dermal matrix
Perez, ML, Castells-Sala, C, Lopez-Chicon, P, Nieto-Nicolau, N, Aiti, A, Farinas, O, Casaroli-Marano, RP, Porta, O, Vilarrodona, A. Fast protocol for the processing of split-thickness skin into decellularized human dermal matrix. TISSUE & CELL. 2021; 72DOI:10.1016/j.tice.2021.101572. PMID:34119882. IF:2.586(Q2/4D).
01/09/2021
Amniotic membrane extract eye drops for ocular surface diseases: use and clinical outcome in real-world practice
Sabater-Cruz, N, Figueras-Roca, M, Ferran-Fuertes, M, Agusti, E, Martinez-Conesa, EM, Perez-Rodriguez, ML, Vilarrodona, A, Casaroli-Marano, RP. Amniotic membrane extract eye drops for ocular surface diseases: use and clinical outcome in real-world practice. INTERNATIONAL OPHTHALMOLOGY. 2021; 41(9)DOI:10.1007/s10792-021-01856-4. PMID:33864578. IF:2.029(Q3/7D).
02/07/2021
Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties
Samarkanova, D, Cox, S, Hernandez, D, Rodriguez, L, Perez, ML, Madrigal, A, Vilarrodona, A, Querol, S, Casaroli-Marano, RP. Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-93150-7. PMID:34215804. IF:4.997(Q2/3D).
01/07/2021
Clinical evaluation of allogeneic eye drops from cord blood platelet lysate
Samarkanova, D, Martin, S, Bisbe, L, Puig, J, Calatayud-Pinuaga, M, Rodriguez, L, Azqueta, C, Coll, R, Casaroli-Marano, R, Madrigal, A, Rebulla, P, Querol, S, Barcelona Cbed Study Grp. Clinical evaluation of allogeneic eye drops from cord blood platelet lysate. Blood Transfusion. 2021; 19(4)DOI:10.2450/2020.0130-20. PMID:33085593. IF:5.752(Q2/4D).
01/07/2021
Lessons Learned From SARS-CoV-2 Pandemic in Donation and Tissue Banking Activities: Key Takeaways
Piteira, AR, Bofill-Rodenas, AM, Farinas, O, Tabera, J, Vilarrodona, A. Lessons Learned From SARS-CoV-2 Pandemic in Donation and Tissue Banking Activities: Key Takeaways. TRANSPLANTATION. 2021; 105(7)DOI:10.1097/TP.0000000000003716. PMID:34019361. IF:5.385(Q1/2D).
01/01/2024
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial
Martínez, IR, Avendaño-Solá, C, Da Ros, CV, Llobet, AB, Erce, JAG, Fraile, MIG, Domínguez, LG, Andrés, IV, Velasco, JA, Rodríguez, VPG, Contreras, E, Uranga, SU, Herraiz, ALP, Jimenez-Marco, T, Pérez, AMO, Rodríguez, JLA, Pérez-Olmeda, M, Ramos-Martínez, A, Velasco-Iglesias, A, Cabrera, JLB, Duarte, RF. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial. VOX SANGUINIS. 2024; 119(1)DOI:10.1111/vox.13561. PMID:37986640. IF:1.600(Q3/7D).
25/06/2023
Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation
Regalado-Artamendi, I, Garcia-Fasanella, M, Medina, L, Fernandez-Sojo, J, Esquirol, A, Garcia-Cadenas, I, Martino, R, Briones, J, Sierra, J, Novelli, S. Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation. VOX SANGUINIS. 2023; 118(8)DOI:10.1111/vox.13486. PMID:37356813. IF:1.800(Q3/7D).
01/01/2023
A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience
Fernandez-Sojo J., Delgadillo J., Vives J., Rodriguez L., Mendoza A., Azqueta C., Garcia-Buendia A., Valdivia E., Martorell L., Rubio-Lopez N., Linares M., Alonso S., Ancochea A., Garcfa-Rey, E, García-Muñoz N., Medina L., Querol S.. A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience. CYTOTHERAPY. 2023; 25(1)DOI:10.1016/j.jcyt.2022.07.011. PMID:36041984. IF:3.700(Q1/3D).
27/12/2022
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
Izquierdo, CP, Mingot-Castellano, ME, Fuentes, AEK, Peinado, JGA, Cid, J, Jimenez, MM, Valcarcel, D, Gomez-Segui, I, de la Rubia, J, Martin, P, Goterris, R, Hernandez, L, Tallon, I, Varea, S, Fernandez, M, Garcia-Munoz, N, Vara, M, Zarzoso, MF, Garcia-Candel, F, Paciello, ML, Garcia-Garcia, I, Zalba, S, Campuzano, V, Gala, JM, Estevez, JV, Jimenez, GM, Lorenzo, JLL, Arias, EG, Freiria, C, Sole, M, Idrovo, LFA, Castellet, JCH, Cruz, N, Lavilla, E, PTrez-Montana, A, Atucha, JA, Beltran, MEM, Macias, JRM, Salinas, R, del Rio-Garma, J. Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura. Blood Advances. 2022; 6(24)DOI:10.1182/bloodadvances.2022008028. PMID:35930694. IF:7.500(Q1/2D).
01/10/2022
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry
Fernandez-Sojo, J, Horton, R, Cid, J, Azqueta, C, Garcia-Buendia, A, Valdivia, E, Martorell, L, Rubio-Lopez, N, Codinach, M, Aran, G, Marsal, J, Mussetti, A, Martino, R, Diaz-de-Heredia, C, Ferra, C, Valcarcel, D, Linares, M, Ancochea, A, Garcia-Rey, E, Garcia-Munoz, N, Medina, L, Carreras, E, Villa, J, Lozano, M, Gibson, D, Querol, S. Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry. BONE MARROW TRANSPLANTATION. 2022; 57(10)DOI:10.1038/s41409-022-01750-2. PMID:35804055. IF:4.800(Q1/2D).
01/08/2022
Post thawing viable CD34+Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation
Fernandez-Sojo, J, Cid, J, Azqueta, C, Valdivia, E, Martorell, L, Codinach, M, Marsal, J, Mussetti, A, Esquirol, A, Trabazo, M, Benitez, MI, Ferra, C, Fox, ML, Linares, M, Alonso, E, Garcia-Rey, E, Garcia-Munoz, N, Medina, L, Castillo-Flores, N, Vall-Llovera, F, Garcia, A, Pinacho, A, Talarn, C, Arroba, JG, Coll, R, Santos, M, Valero, O, Carreras, E, Lozano, M, Querol, S. Post thawing viable CD34+Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation. BONE MARROW TRANSPLANTATION. 2022; 57(8)DOI:10.1038/s41409-022-01722-6. PMID:35614316. IF:4.800(Q1/2D).